Doctor and business man holding up medication concepts Employers are suspicious about the lack of transparency in setting drug prices, and wary about what they perceive as their overdependence on PBMs in setting those prices. (Image: Shutterstock)

A new report sheds light on possible strategies for holding down drug costs for enrollees of employer health plans. Addressing perceived waste and lack of transparency around the practices of pharmacy benefit managers (PBMs) top the list, according to the study.

The report, by the National Alliance of Healthcare Purchaser Coalitions (National Alliance), used surveys and roundtables to take the pulse of more than 80 employers of different sizes from across the country.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.